HEADER TRANSFERASE 07-FEB-22 7R3O TITLE PARP15 CATALYTIC DOMAIN IN COMPLEX WITH OUL40 COMPND MOL_ID: 1; COMPND 2 MOLECULE: PROTEIN MONO-ADP-RIBOSYLTRANSFERASE PARP15; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: ADP-RIBOSYLTRANSFERASE DIPHTHERIA TOXIN-LIKE 7,ARTD7,B- COMPND 5 AGGRESSIVE LYMPHOMA PROTEIN 3,POLY [ADP-RIBOSE] POLYMERASE 15,PARP- COMPND 6 15; COMPND 7 EC: 2.4.2.-; COMPND 8 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: PARP15, BAL3; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS MONO-ADP-TRANSFERASE, INHIBITOR, COMPLEX, TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR M.M.MAKSIMAINEN,S.MURTHY,L.LEHTIO REVDAT 3 07-FEB-24 7R3O 1 REMARK REVDAT 2 08-FEB-23 7R3O 1 JRNL REVDAT 1 25-JAN-23 7R3O 0 JRNL AUTH S.MURTHY,M.G.NIZI,M.M.MAKSIMAINEN,S.MASSARI,J.ALAVIUHKOLA, JRNL AUTH 2 B.E.LIPPOK,C.VAGAGGINI,S.T.SOWA,A.GALERA-PRAT,Y.ASHOK, JRNL AUTH 3 H.VENKANNAGARI,R.PRUNSKAITE-HYYRYLAINEN,E.DREASSI,B.LUSCHER, JRNL AUTH 4 P.KORN,O.TABARRINI,L.LEHTIO JRNL TITL [1,2,4]TRIAZOLO[3,4- B ]BENZOTHIAZOLE SCAFFOLD AS VERSATILE JRNL TITL 2 NICOTINAMIDE MIMIC ALLOWING NANOMOLAR INHIBITION OF JRNL TITL 3 DIFFERENT PARP ENZYMES. JRNL REF J.MED.CHEM. V. 66 1301 2023 JRNL REFN ISSN 0022-2623 JRNL PMID 36598465 JRNL DOI 10.1021/ACS.JMEDCHEM.2C01460 REMARK 2 REMARK 2 RESOLUTION. 2.20 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.8.0238 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.20 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 43.50 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 3 NUMBER OF REFLECTIONS : 24541 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.205 REMARK 3 R VALUE (WORKING SET) : 0.203 REMARK 3 FREE R VALUE : 0.242 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 1292 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.20 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.26 REMARK 3 REFLECTION IN BIN (WORKING SET) : 1795 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 100.0 REMARK 3 BIN R VALUE (WORKING SET) : 0.2930 REMARK 3 BIN FREE R VALUE SET COUNT : 94 REMARK 3 BIN FREE R VALUE : 0.3270 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3193 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 17 REMARK 3 SOLVENT ATOMS : 88 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 31.35 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -3.20000 REMARK 3 B22 (A**2) : -1.04000 REMARK 3 B33 (A**2) : 4.25000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.246 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.199 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.168 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 7.052 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.948 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.926 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 3299 ; 0.008 ; 0.013 REMARK 3 BOND LENGTHS OTHERS (A): 2888 ; 0.001 ; 0.017 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 4476 ; 1.515 ; 1.658 REMARK 3 BOND ANGLES OTHERS (DEGREES): 6725 ; 1.250 ; 1.579 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 393 ; 7.457 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 186 ;33.017 ;22.688 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 534 ;15.505 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 18 ;19.463 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 417 ; 0.065 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 3725 ; 0.006 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): 725 ; 0.001 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS U VALUES : REFINED INDIVIDUALLY REMARK 4 REMARK 4 7R3O COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 08-FEB-22. REMARK 100 THE DEPOSITION ID IS D_1292120858. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 01-JUL-18 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : DIAMOND REMARK 200 BEAMLINE : I04 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.97950 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XSCALE REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 25834 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.200 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 200 DATA REDUNDANCY : 6.600 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 7.8000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.20 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.26 REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: 3BLJ REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 49.09 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.42 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.2 M AMMONIUM CHLORIDE PH 7.5, 16 - REMARK 280 20% (W/V) PEG 3350, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE REMARK 280 295K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 22.62000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 79.28500 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 34.27000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 79.28500 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 22.62000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 34.27000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 2450 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 19350 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -6.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 458 REMARK 465 HIS A 459 REMARK 465 HIS A 460 REMARK 465 HIS A 461 REMARK 465 HIS A 462 REMARK 465 HIS A 463 REMARK 465 HIS A 464 REMARK 465 SER A 465 REMARK 465 SER A 466 REMARK 465 GLY A 467 REMARK 465 VAL A 468 REMARK 465 ASP A 469 REMARK 465 LEU A 470 REMARK 465 GLY A 471 REMARK 465 THR A 472 REMARK 465 GLU A 473 REMARK 465 ASN A 474 REMARK 465 LEU A 475 REMARK 465 TYR A 476 REMARK 465 PHE A 477 REMARK 465 GLN A 478 REMARK 465 SER A 479 REMARK 465 MET A 480 REMARK 465 ASN A 481 REMARK 465 MET B 458 REMARK 465 HIS B 459 REMARK 465 HIS B 460 REMARK 465 HIS B 461 REMARK 465 HIS B 462 REMARK 465 HIS B 463 REMARK 465 HIS B 464 REMARK 465 SER B 465 REMARK 465 SER B 466 REMARK 465 GLY B 467 REMARK 465 VAL B 468 REMARK 465 ASP B 469 REMARK 465 LEU B 470 REMARK 465 GLY B 471 REMARK 465 THR B 472 REMARK 465 GLU B 473 REMARK 465 ASN B 474 REMARK 465 LEU B 475 REMARK 465 TYR B 476 REMARK 465 PHE B 477 REMARK 465 GLN B 478 REMARK 465 SER B 479 REMARK 465 MET B 480 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LYS A 581 CG CD CE NZ REMARK 470 ASN B 481 CG OD1 ND2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASN A 552 50.06 -113.82 REMARK 500 LYS A 581 27.61 -77.64 REMARK 500 TYR A 604 -69.03 -104.01 REMARK 500 HIS B 491 -13.15 71.86 REMARK 500 TYR B 604 -69.44 -99.90 REMARK 500 ASN B 653 116.75 -160.26 REMARK 500 REMARK 500 REMARK: NULL DBREF 7R3O A 481 678 UNP Q460N3 PAR15_HUMAN 481 678 DBREF 7R3O B 481 678 UNP Q460N3 PAR15_HUMAN 481 678 SEQADV 7R3O MET A 458 UNP Q460N3 INITIATING METHIONINE SEQADV 7R3O HIS A 459 UNP Q460N3 EXPRESSION TAG SEQADV 7R3O HIS A 460 UNP Q460N3 EXPRESSION TAG SEQADV 7R3O HIS A 461 UNP Q460N3 EXPRESSION TAG SEQADV 7R3O HIS A 462 UNP Q460N3 EXPRESSION TAG SEQADV 7R3O HIS A 463 UNP Q460N3 EXPRESSION TAG SEQADV 7R3O HIS A 464 UNP Q460N3 EXPRESSION TAG SEQADV 7R3O SER A 465 UNP Q460N3 EXPRESSION TAG SEQADV 7R3O SER A 466 UNP Q460N3 EXPRESSION TAG SEQADV 7R3O GLY A 467 UNP Q460N3 EXPRESSION TAG SEQADV 7R3O VAL A 468 UNP Q460N3 EXPRESSION TAG SEQADV 7R3O ASP A 469 UNP Q460N3 EXPRESSION TAG SEQADV 7R3O LEU A 470 UNP Q460N3 EXPRESSION TAG SEQADV 7R3O GLY A 471 UNP Q460N3 EXPRESSION TAG SEQADV 7R3O THR A 472 UNP Q460N3 EXPRESSION TAG SEQADV 7R3O GLU A 473 UNP Q460N3 EXPRESSION TAG SEQADV 7R3O ASN A 474 UNP Q460N3 EXPRESSION TAG SEQADV 7R3O LEU A 475 UNP Q460N3 EXPRESSION TAG SEQADV 7R3O TYR A 476 UNP Q460N3 EXPRESSION TAG SEQADV 7R3O PHE A 477 UNP Q460N3 EXPRESSION TAG SEQADV 7R3O GLN A 478 UNP Q460N3 EXPRESSION TAG SEQADV 7R3O SER A 479 UNP Q460N3 EXPRESSION TAG SEQADV 7R3O MET A 480 UNP Q460N3 EXPRESSION TAG SEQADV 7R3O MET B 458 UNP Q460N3 INITIATING METHIONINE SEQADV 7R3O HIS B 459 UNP Q460N3 EXPRESSION TAG SEQADV 7R3O HIS B 460 UNP Q460N3 EXPRESSION TAG SEQADV 7R3O HIS B 461 UNP Q460N3 EXPRESSION TAG SEQADV 7R3O HIS B 462 UNP Q460N3 EXPRESSION TAG SEQADV 7R3O HIS B 463 UNP Q460N3 EXPRESSION TAG SEQADV 7R3O HIS B 464 UNP Q460N3 EXPRESSION TAG SEQADV 7R3O SER B 465 UNP Q460N3 EXPRESSION TAG SEQADV 7R3O SER B 466 UNP Q460N3 EXPRESSION TAG SEQADV 7R3O GLY B 467 UNP Q460N3 EXPRESSION TAG SEQADV 7R3O VAL B 468 UNP Q460N3 EXPRESSION TAG SEQADV 7R3O ASP B 469 UNP Q460N3 EXPRESSION TAG SEQADV 7R3O LEU B 470 UNP Q460N3 EXPRESSION TAG SEQADV 7R3O GLY B 471 UNP Q460N3 EXPRESSION TAG SEQADV 7R3O THR B 472 UNP Q460N3 EXPRESSION TAG SEQADV 7R3O GLU B 473 UNP Q460N3 EXPRESSION TAG SEQADV 7R3O ASN B 474 UNP Q460N3 EXPRESSION TAG SEQADV 7R3O LEU B 475 UNP Q460N3 EXPRESSION TAG SEQADV 7R3O TYR B 476 UNP Q460N3 EXPRESSION TAG SEQADV 7R3O PHE B 477 UNP Q460N3 EXPRESSION TAG SEQADV 7R3O GLN B 478 UNP Q460N3 EXPRESSION TAG SEQADV 7R3O SER B 479 UNP Q460N3 EXPRESSION TAG SEQADV 7R3O MET B 480 UNP Q460N3 EXPRESSION TAG SEQRES 1 A 221 MET HIS HIS HIS HIS HIS HIS SER SER GLY VAL ASP LEU SEQRES 2 A 221 GLY THR GLU ASN LEU TYR PHE GLN SER MET ASN LEU PRO SEQRES 3 A 221 GLU HIS TRP THR ASP MET ASN HIS GLN LEU PHE CYS MET SEQRES 4 A 221 VAL GLN LEU GLU PRO GLY GLN SER GLU TYR ASN THR ILE SEQRES 5 A 221 LYS ASP LYS PHE THR ARG THR CYS SER SER TYR ALA ILE SEQRES 6 A 221 GLU LYS ILE GLU ARG ILE GLN ASN ALA PHE LEU TRP GLN SEQRES 7 A 221 SER TYR GLN VAL LYS LYS ARG GLN MET ASP ILE LYS ASN SEQRES 8 A 221 ASP HIS LYS ASN ASN GLU ARG LEU LEU PHE HIS GLY THR SEQRES 9 A 221 ASP ALA ASP SER VAL PRO TYR VAL ASN GLN HIS GLY PHE SEQRES 10 A 221 ASN ARG SER CYS ALA GLY LYS ASN ALA VAL SER TYR GLY SEQRES 11 A 221 LYS GLY THR TYR PHE ALA VAL ASP ALA SER TYR SER ALA SEQRES 12 A 221 LYS ASP THR TYR SER LYS PRO ASP SER ASN GLY ARG LYS SEQRES 13 A 221 HIS MET TYR VAL VAL ARG VAL LEU THR GLY VAL PHE THR SEQRES 14 A 221 LYS GLY ARG ALA GLY LEU VAL THR PRO PRO PRO LYS ASN SEQRES 15 A 221 PRO HIS ASN PRO THR ASP LEU PHE ASP SER VAL THR ASN SEQRES 16 A 221 ASN THR ARG SER PRO LYS LEU PHE VAL VAL PHE PHE ASP SEQRES 17 A 221 ASN GLN ALA TYR PRO GLU TYR LEU ILE THR PHE THR ALA SEQRES 1 B 221 MET HIS HIS HIS HIS HIS HIS SER SER GLY VAL ASP LEU SEQRES 2 B 221 GLY THR GLU ASN LEU TYR PHE GLN SER MET ASN LEU PRO SEQRES 3 B 221 GLU HIS TRP THR ASP MET ASN HIS GLN LEU PHE CYS MET SEQRES 4 B 221 VAL GLN LEU GLU PRO GLY GLN SER GLU TYR ASN THR ILE SEQRES 5 B 221 LYS ASP LYS PHE THR ARG THR CYS SER SER TYR ALA ILE SEQRES 6 B 221 GLU LYS ILE GLU ARG ILE GLN ASN ALA PHE LEU TRP GLN SEQRES 7 B 221 SER TYR GLN VAL LYS LYS ARG GLN MET ASP ILE LYS ASN SEQRES 8 B 221 ASP HIS LYS ASN ASN GLU ARG LEU LEU PHE HIS GLY THR SEQRES 9 B 221 ASP ALA ASP SER VAL PRO TYR VAL ASN GLN HIS GLY PHE SEQRES 10 B 221 ASN ARG SER CYS ALA GLY LYS ASN ALA VAL SER TYR GLY SEQRES 11 B 221 LYS GLY THR TYR PHE ALA VAL ASP ALA SER TYR SER ALA SEQRES 12 B 221 LYS ASP THR TYR SER LYS PRO ASP SER ASN GLY ARG LYS SEQRES 13 B 221 HIS MET TYR VAL VAL ARG VAL LEU THR GLY VAL PHE THR SEQRES 14 B 221 LYS GLY ARG ALA GLY LEU VAL THR PRO PRO PRO LYS ASN SEQRES 15 B 221 PRO HIS ASN PRO THR ASP LEU PHE ASP SER VAL THR ASN SEQRES 16 B 221 ASN THR ARG SER PRO LYS LEU PHE VAL VAL PHE PHE ASP SEQRES 17 B 221 ASN GLN ALA TYR PRO GLU TYR LEU ILE THR PHE THR ALA HET I1Q A 701 13 HET DMS B 701 4 HETNAM I1Q 6-METHYL-[1,2,4]TRIAZOLO[3,4-B][1,3]BENZOTHIAZOLE HETNAM DMS DIMETHYL SULFOXIDE HETSYN I1Q 7-METHYL(1,2,4)TRIAZOLO(3,4-B)(1,3)BENZOTHIAZOLE FORMUL 3 I1Q C9 H7 N3 S FORMUL 4 DMS C2 H6 O S FORMUL 5 HOH *88(H2 O) HELIX 1 AA1 GLN A 503 SER A 518 1 16 HELIX 2 AA2 ALA A 531 ASP A 549 1 19 HELIX 3 AA3 ASP A 562 ASP A 564 5 3 HELIX 4 AA4 SER A 565 GLY A 573 1 9 HELIX 5 AA5 ASP A 595 ALA A 600 1 6 HELIX 6 AA6 GLN B 503 ARG B 515 1 13 HELIX 7 AA7 ALA B 531 ASN B 548 1 18 HELIX 8 AA8 ASP B 562 ASP B 564 5 3 HELIX 9 AA9 SER B 565 GLY B 573 1 9 HELIX 10 AB1 ASN B 575 ALA B 579 5 5 HELIX 11 AB2 ASP B 595 LYS B 601 1 7 SHEET 1 AA1 5 PHE A 494 GLN A 498 0 SHEET 2 AA1 5 ALA A 521 ASN A 530 -1 O GLN A 529 N CYS A 495 SHEET 3 AA1 5 ALA A 668 THR A 677 -1 O THR A 677 N ALA A 521 SHEET 4 AA1 5 LYS A 613 LEU A 621 -1 N LYS A 613 O PHE A 676 SHEET 5 AA1 5 GLU A 554 THR A 561 -1 N LEU A 557 O VAL A 618 SHEET 1 AA2 4 THR A 590 ALA A 593 0 SHEET 2 AA2 4 LEU A 659 VAL A 662 -1 O VAL A 662 N THR A 590 SHEET 3 AA2 4 SER A 649 THR A 651 -1 N VAL A 650 O VAL A 661 SHEET 4 AA2 4 PHE A 625 LYS A 627 1 N THR A 626 O THR A 651 SHEET 1 AA3 5 PHE B 494 GLN B 498 0 SHEET 2 AA3 5 ALA B 521 ASN B 530 -1 O ARG B 527 N VAL B 497 SHEET 3 AA3 5 ALA B 668 THR B 677 -1 O GLU B 671 N ILE B 528 SHEET 4 AA3 5 LYS B 613 LEU B 621 -1 N LYS B 613 O PHE B 676 SHEET 5 AA3 5 GLU B 554 THR B 561 -1 N LEU B 557 O VAL B 618 SHEET 1 AA4 4 THR B 590 ALA B 593 0 SHEET 2 AA4 4 LEU B 659 VAL B 662 -1 O VAL B 662 N THR B 590 SHEET 3 AA4 4 SER B 649 THR B 651 -1 N VAL B 650 O VAL B 661 SHEET 4 AA4 4 PHE B 625 LYS B 627 1 N THR B 626 O THR B 651 CRYST1 45.240 68.540 158.570 90.00 90.00 90.00 P 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.022104 0.000000 0.000000 0.00000 SCALE2 0.000000 0.014590 0.000000 0.00000 SCALE3 0.000000 0.000000 0.006306 0.00000